Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism
NCT : NCT02756754 · COMPLETED
Publicité
ID NCTNCT02756754
StatutCOMPLETED
Date de début2016-11-07
Achèvement2019-05-10
Résumé succinct
The aim of the study is to evaluate the novel use of adrenal radiofrequency ablation on a prospective cohort of patients with primary aldosteronism and unilateral adrenal adenoma concerning the efficacy on blood pressure control. The safety of the procedure is one of the secondary outcomes.
Source officielle
Voir sur ClinicalTrials.gov →Données issues de l’API ClinicalTrials.gov. Pour connaître le statut le plus récent, consultez la fiche officielle.